Objective: Leiomyosarcoma and ovarian cancer are often diagnosed late due to the absence of initial symptoms. Patients seek help when abdominal distension occurs; this is associated with pelvic tumor and carcinomatosis. Initial imaging often reveals pelvic tumors with diffuse abdominal nodules; however, this imaging could be misleading, such as in the cases of splenosis.
Case Report: A female presented with vaginal bleeding at our outpatient department. Serum CA125 level was elevated. Abdominal and pelvic CT showed multiple uterine masses and left adnexal cysts with peritoneal nodules. Leiomyosarcoma or ovarian cancer with carcinomatosis was suspected. Exploratory laparotomy was performed. Multiple purple spots spreading over peritoneal cavity were noted during the surgery. Pathological examination revealed adenomyosis with multiple uterine myomas and left ovarian endometrioma. Splenic tissues peritoneal implants were observed.
Conclusion: In patients with a history of spleen rupture or splenectomy, splenosis should be considered in the differential diagnosis, especially in young patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.tjog.2020.07.028 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies.
BMC Cancer
December 2024
Department of Clinical Therapeutics, Medical School, Alexandra Hospital, 11528, Athens, Greece.
Article Synopsis
- HER2 overexpression is a significant target for treating gynecological cancers, and Trastuzumab-Deruxtecan (T-DXd) has shown notable effectiveness against these cancers, particularly in ovarian, endometrial, and cervical malignancies.
- A study was conducted at the Alexandra Hospital in Athens involving 10 patients with HER2-positive gynecological cancers who were treated with T-DXd, administered intravenously every 3 weeks.
- Results indicated a median progression-free survival of 5.4 months, with 5 patients achieving a partial response, highlighting T-DXd's potential as a treatment option even for patients with prior therapies.
Artificial Intelligence in Obstetric and Gynecological MR Imaging.
Magn Reson Med Sci
October 2024
Department of Diagnostic and Interventional Radiology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Article Synopsis
- The review highlights advancements in the use of artificial intelligence (AI) in obstetrics and gynecological MRI, detailing its evolution from basic algorithms to deep learning techniques.
- It discusses recent research utilizing AI to identify various medical conditions like uterine leiomyosarcoma and endometrial cancer, as well as improvements in MRI segmentation and quality.
- The text notes ongoing challenges in the field while emphasizing the potential of AI to enhance diagnostic accuracy and support personalized medicine through better access to large datasets and multiparametric MRI technology.
Smooth Muscle Surprise: Documenting a Primary Ovarian Leiomyosarcoma Case.
Cureus
September 2024
Department of Pathology, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technnical Sciences, Saveetha University, Chennai, IND.
Primary ovarian leiomyosarcoma (LMS) is an extremely rare and aggressive tumor that originates in the smooth muscle tissue of the ovary. Typically affecting older women, it is diagnosed at an advanced stage and is associated with a poor prognosis, with most patients succumbing within the first year. The effectiveness of adjuvant chemotherapy and radiotherapy remains unclear due to the rarity of reported cases.
View Article and Find Full Text PDFUterine Sarcoma or Degenerating Fibroid? Validating the New Consensus Magnetic Resonance Imaging Algorithm for Evaluating Atypical Uterine Masses.
J Comput Assist Tomogr
January 2025
From the Department of Radiology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL.
Article Synopsis
- The study evaluated a new MRI diagnostic algorithm designed to distinguish between benign uterine leiomyomas and malignant uterine sarcomas in atypical cases.
- Researchers reviewed 40 cases of atypical uterine masses and found that the algorithm had strong accuracy metrics, with sensitivity and specificity rates around 75% and 95%, respectively.
- The results indicate that the consensus MRI algorithm is effective, achieving even higher accuracy when focusing on leiomyosarcomas, suggesting it could be a valuable tool for radiologists.
On the Origin of Abdominal Venous Leiomyosarcomas: The Role of the Sex-Hormone Drainage Pathways.
World J Oncol
October 2024
Department of Medical Imaging, University of Toronto, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada.
Article Synopsis
- The study investigates abdominal venous leiomyosarcoma (AV-LMS), focusing on its origins from veins associated with the sex-hormone drainage pathway (SHDP).
- A retrospective analysis of imaging from 155 patients with confirmed non-uterine abdominal/pelvic LMS revealed that more than half of the tumors originated from venous structures, particularly those linked to the SHDP, including adrenal and ovarian veins.
- Key findings indicate that tumors from the SHDP are prevalent and may lead to a lower risk of distant metastases at diagnosis, with tumor size and SHDP origin being critical factors in predicting metastasis risk.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!